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All agents used for myocardial contrast echocardiography
to date produce adverse hemotynamie effects and alter
coronary blood flow . It was hypothesized that because 5%
human albumin, when sonicated for it* as a contrast agent,
is neither hyperosmolar nor a calcium chelator, it would
not have significant effects on coronary blood flow, left
ventricular
function or systemic hemodynamics . Albumin
microbubbles of two distinct sizes (mean size 2.9 and 5.8
pm) were produced and compared with nonsonicated albu.
min, noasenicated Renografin, sonicated Renografin and
hand-ngilated Renografin for their effects on henodynam-
ics, coronary blood flow and regional left ventricular sys-
lolje thickening in 15 open chest anesthetized dogs .
Name of the albumin solution significantly altered left
atria], left vNmAcult r systolic and tad-diastolic and mean
aortic pressures . These agents did not cause a coronary
hyperemic response or alter left ventricular systolic thick-
ening, but slightly lowered the peak positive left ventricular
Myocardial contrast echocardiography utilizes the intracor-
onary or intraacrtic injection of microbubble solutions to
U
From the Division of Cardiology . Department of Medicine, University of
Virginia School of Medicine . Charlonesville, Virginia. This work was
u"penned in pan by a grant-in-aid from the National Center of the American
Heart Association, Dallas, Texas with the funds contributed in pan by the
Virginia Alalisle, Glen Allen, Virginia and Grant No
. ROI-HL27014 from the
National Institutes of Health . Bethesda. Maryland. Dr . Keller was the
recipient of a fellowship grant from the Virginia
Affiliate
of the American
Association and is currently the recipient of Fellowship Grant F32-
502 from the National Institutes of Health . Bethesda, Maryland . Dr.
Kaul is recipient of Clinical Investigator
Award K08-HL-01833 and FIRST
Award R29-HLd8345 of the National Institutes of Health. This study was
presented in pan al the 60th Annual Scientific Session of the American Heart
Association, Anaheim, California. November 1987 and in pan at the 37th
Annual Meeting of the American College of Cardiology . Atlanta, Georgia .
March 1988.
Manuscript received November 16, 1987 ; revised manuscript received
May 6, 1988, accepted May 10, 1988 .
Address far repriWS : Saejiv Kaul, MD, Division of Cardiology,
Box 158 .
University of Virginia School of Medicine, Charlottesville, Virginia 22900 .
01988 by the American College ol`Cmdiology
maximal rate of rise in pressure (dP/dt) (-4.1 t 5 .4%, p <
0 .01) . In contrast, all the Renografm solutions caused
significant changes in all these variables (p < 0.02). In six
dogs, albumin solutions did not alter these variables even in
the presence of critical coronary stenasis. The contrast
opacification produced
by 5.8
;am albumin miceabubbtes
was equivalent to that produced by sonicated Reoagrafia.
Compared with an equivalent amount of salioe and oon-
sonicated albumin solutions, 10 M of soncated albumin did
not produce any evidence of infarction, embolization or
hemorrhage in the myocardium, brain or hidmys of rab-
hits .
In cotxlusion, intracoonary injection of sonicated atbu .
min does not alter coronary blood flow, left ventricular
function or systemic hemodynamics, offering a major ad-
vantage in the imaging of regional myocardial perfusion .
(J Am Can Cardiol 1988 ;12 :1039-47)
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define the size and extent of coronary perfusion beds in vivo
(1-5). The measurement of regional my3cardial blood flow
(6-9) and coronary blood flow reserve (10,11) may also be
possible using this technique, However, to accurately depict
myocardial blood flow, microbubble solutions should not
alter coronary blood flow, left ventricular function or sys-
temic hemodynamics when injected into the coronary circu-
lation ; all agents used to date for myocardial contrast echo-
cardiography produce significant changes in these variables
(12-18) . Many of the adverse hemodynamic
effects caused
by these agents have been minimized by the use of
smaller
microbubbles (4 to 8µm in diameter) produced by sonication
(12,16). However, the carrier solutions in
which these micro-
bubbles are generated continue to produce significant effects
on coronary blood flow, left vr .rtricufar function and sys-
temic hemodynamics (12,16,19-21) despite an absence of
significant pathologic effects on the different body organs
(14)
.
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Studies in the hamster microcirculalion have demon-
strated that the behavior of sonicated albumin microbubbles
closely mimics that of red blood cells, supporting the use of
albumin microbubbles as intravascular tracers of red blood
cell flow during myocardial contrast echocardiography (22)
.
Albumin microbubbles have also been shown to opacify the
left ventricular cavity after a peripheral intravenous injection
in dogs (23). Human albumin is not known to have the direct
myocardial depressant . calcium chelating or hyperosmolar
properties exhibited by Renografin, which is the most com-
monly employed contrast agent used in other roentgeno-
graphic imaging modalities, such as tine-computed tomog-
raphy and digital subtraction angiography (19-21) .
We hypothesized that sonicated albumin microbubbles
would not alter coronary blood flow during their transit
through the coronary circulation and would not significantly
affect left ventricular function or systemic hemodynamics .
Using sonication, we produced albumin microbubbles that
were tested against nonsonicated albumin and a variety o`
Renografin solutions for their effects on coronary blood flow,
left ventricular function and systemic hemodynamics, as
well as their contrast opacification . We also tested sonicated
albumin for any pathologic changes induced in the heart,
kidneys and brain .
Methods
In Vitro Studies
Contrast agent preparation. A commercially available
sonicating system (model W-375, Heat Systems Ultrasonics
Corp.) was used to make microbubbles, which were pre-
pared in 10 ml plastic syringes (Becton Dickinson Co .) . Eight
milliliters of Renografin-76 (diatrizoate meglumine and dia-
trizoate sodium, 18,5 g/ml) was sonicated at 20,000 Hz at a
power output of 110 W for 30 s . This method of sonication
has been described previously (24) . Eight milliliters of 5%
human albumin solution (New York Blood Center) was
sonicated at 20,000 Hz at a power output of 210 W for 40 s .
One minute after the completion of sonication, a layer of
foam formed on the surface of the solution . The fluid below
this foam was drained into a separate syringe
. The residual
foamy layer was then resuspended in 7 ml of nonsonicated
albumin .
Assessment of microbubble size, concentration and half-
lire . The foamy layer and the nonfoamy layer of 15 sepa-
rately sonicaled aliquots of albumin were assessed for micro-
bubble size and concentration, which was determined with
an Electrozone Celloscope particle counter (model 112
LTH, Particle Data, Inc .) . One hundred microliter samples
were suspended in 10 ml of normal saline solution and placed
on the stage of the particle counter for determination of the
size and concentration of the suspended microbubbles ('35) .
The sizes of Renografin microbubbles from 10 separate
aliquots of sonicated and hand-agitated Renografin were
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determined with a light microscope (model CHA-50,
Olympus Optical Co
.) equipped with a net relicle eyepiece as
previously described (7) . It was not possible to determine the
sizes of Renografin-76 microbubbles with the particle
counter because the microbubbles decayed too rapidly after
suspension in 0 .9% saline solution to be counted . The in
vitro half-lives of albumin microbubbles were determined by
measuring the number of microbubbles per microliter from
the sane aloquots 2 h apart . The half-life of Renografin-76
microbubbles was estimated by measuring the number of
microbubbles within the same low power field of the light
microscope I min apart
. In each case, half-life (th) was
estimated using the following equation :
ty _
	(t)ln2
In l(NJ/(N2)1
where t is the interval between counting the two samples (in
minutes) and N, and N 2
are the number of microbubbles at
the first and the second observation, respectively
.
Hemodynamic and Echoeardiographic Studies
Animal model. Fifteen mongrel dogs (mean ± I SD
weight = 26 ± 3 kg) were anesthetized with 30 mg/kg body
weight pentobarbital sodium (Abbott Laboratories), into-
bated and ventilated with a dual phase control respirator
pump (model 607, Harvard Apparatus) . Additional anesthe-
sia was given as needed during the experiment . An SP
catheter was inserted into the femoral vein and both femoral
arteries for continuous recording of arterial pressure, moni-
toring of arterial blood gases and administration of intrave-
nous fluids and drugs as needed . A micromanometer-tipped
catheter (model PC-484B, Millar Instruments) was inserted
into the left ventricular cavity by way of the left carotid
artery for the measurement of the first derivative of left
ventricular pressure (dP/dt) and left ventricular end-diastolic
and systolic pressures . A left thoracotomy was performed
and the heart was suspended in a pericardial cradle . A 4F
catheter was inserted into the left atrium through the left
atrial appendage for monitoring left atrial pressure.
The left anterior descending coronary artery was dis-
sected free from surrounding tissues and a 20 gauge intra-
vascular Teflon catheter (Travenol Laboratories) was in-
serted through its anterior wall and its tip positioned at the
bifurcation of the left main cororary artery (Fig. I). This
catheter was used for the injection of contrast agents . An
appropriately sized electromagnetic flow probe (model
EP406, Carolina Medical Electronics, Inc.) was attached to
either the left anterior descending (six dogs) or the left
circumflex (nine dogs) coronary artery to measure coronary
blood flow. In the last six dogs, a fluid-filled hydraulic
occiuder was placed snugly around the left circumflex cor-
onary artery just distal to the electromagnetic flow probe
(Fig. I) . Left atrial, left ventricular and arterial pressures
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Figure
1. Diagrammatic representation of the open chest canine
model used to study the effects of contrast agents
on left ventricular
and systemic hemedynamics and coronary blood flow Isee text for
details).
were obtained on a strip chart recorder (model 4568C,
Hewlett-Packard) by means of fluid-filled transducers (model
1290-A, Hewlett-Packard) placed at the level of the right
atrium
. Left ventricular dP/dt and coronary blood flow were
also obtained on the same recorder.
Hemodynamic measurements. All hemodynamic mea-
surements were made from data recorded on the multichan-
nel physiologic recorder . These included left atria, left
ventricular end-diastolic and systolic
and aortic pressures,
peak positive left ventricular dP/dt and coronary
blood flow
.
Measurements were made before and 5, 10, 15 and 20 s after
each injection . In the case of hand-agitated Renagrafln,
measurements were also made at the time of peak hyperemic
response, which usually occurred later
. Each measurement
consisted of the average of three signals closest to the
specified time . Hemodynamic data were expressed as per-
cent change from baseline . Change in coronary blood flow
was expressed as a percent of the maximal hyperemic
response induced by a 20 s mechanical occlusion, which was
performed in each dog at the beginning of the
protocol .
Two-dimensional echocardiography . Two-dimensional
echocardiography was performed with the use of a commer-
cially available sector scanning system equipped with a 5
MHz fluid-filled rotating element transducer (Mark 111, Ad-
vanced Technology Laboratories) . Images were recorded on
a 0 .5 in. (1
.27 cm) video tape recorder (Panasonic NV-8950,
Matsushita Electrical Industrial
Co .)
. The transducer was
fixed at an optimal
mid-papillary
muscle short-axis level with
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the use of a clamp attached to the procedure table (4) .
Gain
settings were optimized at the beginning of each experiment
and kept constant throughout the recording period . A saline
bath acted as an acoustic interface between the transducer
and the heart (4)
. The injection sequence was timed with a
character generator (model G58, Medical Diagnostic Serv
.
ices), which projected the time in hundredths of seconds
onto the ultrasound video image . A standard limb lead
electrocardiogram (ECG) was recorded concomitantly with
the echocareliographic images on videotape .
Images were analyzed on an off line image analysis
computer (Mipron System, Kontron Electronics) . Images
were transferred from videotape to the computer in a 340 x
240 x 8 format. For analysis of wall thickening, single
end-diastolic and end-systolic images before and at 5 and 20
s after each injection were then identified . The endocardial
and epicardial outlines and the right ventricular free wall-left
ventricular posterior wall junction were defined by the
operator. The computer then determined a defined number
of equally spaced points along the epicardial outline of the
left ventricle starting from the right ventricular free wall-left
ventricular posterior wall junction for both end-diastolic and
end-systolic frames. This measure corrects for cardiac rota-
tion between end-diastole and end-systole. From these
points, chords representing the shortest possible distance
between the epicardial and the endocardial outlines were
automatically drawn by the computer. Because the chords
were drawn inward from the epicardium, this method of
measuring wall thickness is not dependent on a center of
reference . In experiments without critical stenosis where
regional dysfunction did not occur, wall thickness was
measured at 16 equally spaced chords along the circumfer-
ence of the left ventricle . Previous studies (26) have shown
as few as 12 chords to be sufficient when assessing wall
thickening in a short-axis slice of the left ventricle . Average
systolic thickening along the circumference of the left ven-
tricle was then expressed as percent change between mean
end-systolic and end-diastolic left ventricular wall thickness,
respectively .
In experiments with critical coronary slenosis where
regional dysfunction was possible, wall thickness was mea-
sured at 64 equally spaced chords along the left ventricular
epicardial circumference . The use of an increased number of
chords in the presence of a critical steaosis allowed for an
acceptable spatial resolution for measuring the extent of
possible
abnormal
wall motion . Once these measurements
were made, the observer identified the regions of myocar-
dium supplied by the stenotic and the normal vessels . Mean
percent thickening was then calculated in each region .
Videadensilametrie analysis was performed to assess tire
contrast enhancement produced by injections of ail six
solutions in all 15 dogs. Single end-diastolic frames before
contrast injection and at peak contrast effect were trans-
ferred to the computer for each injection . An area of interest
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(mean 275 ± 80 pixels) was determined with a hand-held
cursor for each image, and the mean pixel video intensity (0
to 255) calculated. For each injection, the mean video
intensity before contrast injection was subtracted from the
mean value obtained at peak contrast effect .
Protocol . Arterial blood gases were monitored through-
out the experiment. The respiratory rate and concentration
of oxygen in air (FiO0) were adjusted and intravenous
sodium bicarbonate given accordingly. The following solu-
tions were injected into the coronary circulation in a random
manner
: 5% nonsonicated albumin, albumin microbubbles
from the non-foamy layer, albumin microbubbles from the
foamy layer, nonsonicated Renografin-76, sonicated Reno-
grafin-76 and hand-agitated Renografin-76 . After prepara-
tion, 3 ml of each agent was injected through the catheter
placed in the Jell anterior descending coronary artery. This
catheter has a dead space of 0 .6 ml. An injection of 2 to 3 ml
of contrast agent has been previously shown to produce
optimal myocardial opacification during myocardial contrast
echocardiography
(12) . Five minutes were allowed for re-
covery
between each injection. Hemodynamic data were
recorded on the strip chart recorder at a paper speed of t00
mm/s before and for 20 s after each injection and then at I
mmls for 5 min. The system was calibrated before each
injection . In the last six dogs, a critical stenosis
was placed
on the left circumflex coronary artery and all injections were
repeated . The critical stenosis .vas created by tightening a
micrometer attached to ,he hydraulic occluder until a 6 mg
intracoronary injection of papaverine hydrochloride (Ely
Lilly and Co.) no longer produced a hyperemic response.
After completion of all injections, the dog was killed by
electrocautery of the right ventricle
.
Toxicity Studies
Animal preparation
. These studies were performed in 24
rabbits (mean ± I SD weight = 4 .3 *_ 0.5 kg) . A sterile
femoral artery cutdown was made in each animal after
intramuscular injection of ketamine (50 mg/kg)
and xylazine
(5 mg/kg). The femoral artery was cannulated with a 4F
National Institutes of Health
pediatric catheter (USCI
Corp .), which was advanced into the aortic
root .
Protocol. Six rabbits each underwent on inhaaortic injec-
tion of
10 ml of 0.9% saline solution (group A), 10 ml of 5%
nonsonicated human albumin (group B), 10 ml of sonicated
albumin (group C) and 20 ml of sonicated albumin (group D) .
The catheter was removes
the artery ligated to maintain
hemostasis and the incision closed with 3
.0 silk . The rabbits
were kept alive for 48 h and then killed with a pentobarbital
overdose.
Pathologle studies
. After termination of the experiment,
the heart, kidneys and brain
were removed from each
animal
. A 5 mm thick slice of tissue was removed from each
organ and preserved in formality
. The heart was sectioned at
1aCC Vol . 12. No. 4
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the mid-papillary muscle level, whereas the brain was cut
across the parietal-temporal lobes . Tile kidneys were sec-
tioned longitudinally through the hilum
.
Samples from these
sections were mounted on glass slides, fixed and stained with
Hematoxylin-eosin . Each slide was examined by an experi-
enced cardiac pathologist for evidence of microinfarction,
capillary blockage and hemorrhage .
Statistical Analysis
Statistical analysis was performed on the VAX 8200
minicomputer (Digital Equipment Corp .) with the use of
commercially available software (RS/1, Bolt, Beraneck and
Newman and BMDP, University of California) . Data were
expressed as mean ± I SD and the effects of all contrast
agents compared with the use of analysis of variance with
repeat measures . When analysis of variance demonstrated a
difference between the agents, the Neuman-Keuls multi-
range test was performed to determine the significance of
each comparison . Data in the last six dogs before and after
critical stenosis were compared with the use of the Student's
paired t test. Pathologic data were expressed as
proportions
and groups B, C and D were compared with group A
(control) with the use of the Fisher exact test .
Results
In Vitro Data
The albumin microbubbles in the non-foamy layer had a
mean diameter of 2 .9 t 1 .9 Am and a concentration of 64 x
45 million per milliliter. The albumin microbubbles in the
foamy layer had a mean diameter of 5 .8 ± 2.6 Am and a
concentration of 8 ± 4 million per milliliter. Sonicated
Renografin-76 microbubbles ranged in size from 5 to 10,um
(mean diameter 6 µm) and hand-agitated microbubbles from
5 to 30 µm (mean diameter 14 µm) . The half-life of the 2.9
Am albumin and 5.8 Am microbubbles was 23 .0 and 35-5
min, respectively, whereas that of sonicated and hand-
agitated Renografin was 2 .7 and 8.2 min, respectively.
Hemodynamic and Echocardiographic Data
Hemodynamic data. Whereas all Renografin-76 solutions
produced a reactive hyperemia, none of the
albumin solu-
tions invoked a significant change in
coronary blood flow
(Fig
. 2A). The peak hyperemic response occurred at 10 s for
nonsonicated and sonicated Renografin-76
but was delayed
until 31 s for hand-agitated Renografin-76, which also pro-
duced an initial decrease in coronary blood flow 5 s after
injection
. The maximal increase in coronary blood flow with
nonsonicated albumin was 2
.3 .t 3.3% of maximal hyperemic
response whereas that noted with nonsonicated
Renografin
was 17.3 ± 14
.9% of the maximal hyperemic response (p <
0 .01)
. Addition of microbubbles did not significantly increase
IACC V .I. 12 . No. 4
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Figure 2. Effects of the different contrast agents on A, corcaary
blood flow; 11, peak positive first derivative of left ventricular
pressure (dPldt) ; C, mean aortic pressure ; and 0, we" thickening in
15 dogs . The X axis represents time after injecnoa of contrast
medium into the coronary circulation and the Y axis represents
percent change
. Coronary blood flow is represented as percent of
maximal hyperemic response obtained during a 20 s mechanical
occlusion of the left circumflex coronary artery . 'p < 0 .05 and nnp
< 0.01 compared with albumin solutions .
Solid circles = central
albumin ; solid squares = 2 .9 tom albumin bubbles ; solid triaug/s =
5
.8,um albumin bubbles : open circles = control Renografn-7I, open
squares = sonicated Renografin-76; open triangles = hand- agitated
Renografin-76 .
the hyperemic response of either solution (increases of
2.9 t 6.1% and 2.4 ± 5 .3% for 2 .9 and 5 .8 yam albumin
microbubbles, respectively and 22 .7 ± 16 .0% and 21 .5
t
10.9% for sonicated and hand-agitated Renografin-76, re-
spectively) .
Except for nonsonicated albumin, all solutions produced
a decrease in peak positive left ventricular dp/dt (Fig . 28)
that occurred at 5 s for all solutions except hand-agitated
KFLLER RT At-
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Renogr fin-76 (10 s) and nonsonicated albumin '20 s) . Non-
sonicuted albumin decreased peak positive left veaibwiar
dPldt by 0 .7 t 1 .8% (p = NS) . The addition of microbubbles
to albumin significantly decreased (p < 0
.01) peak positive
left ventricular dP/dt by (4.1 ± 5.4% and 6 .2 ± 7 .7% for 2 .9
and 5 .8 um microbubbles . respectively). Renografin-76 so-
lutions produced a significantly greater (p < 0 .01) decrement
in peak positive left ventricular di'/dt than that caused by
albumin microbubble solutions (a decrease of 13.6 ± 10 .0%,
22.7 ± 16 .0% and 21 .5 t 10.9% for nonsonicated, sonicated
and hand-agitated Renografin-76, respectively) .
The Renografin-76 solutions produced a significant de-
crease in left ventricular systolic pressure that was maximal
at 10 s, whereas albumin solutions produced no changes . A
decrease in left ventricular systolic pressure of 5 .5 t 4.5%
was noted with nonsonicated Renografin compared with a
decrease of only 0 .9 t 3.7% with nonsonicated albumin (p <
0.011 . 'f he addition of microbubbles to either solution did not
significantly affect the change induced in left ventricular
systolic pressure. Similarly, although albumin solutions pro-
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duced no significant change in aortic pressure (change of
-0.6 *- 4.0% for nonsonicated albumin and -2 .0 ± 6 .6% and
1 .8 `- 3 .1% for 2.9 and 5 .8 am albumin microbubbles,
respectively), aortic pressure declined significantly (p <
0 .01) after intracoronary injection of Renografin solutions
(decrease
of
6
.7 ± 4.8%, 7 .1 ± 6.1% and 9.6 ± 7 .3% with
nonsonicated, sonicated and hand-agitated Renogrfin-76 .
respectively) (Fig. 2C) . Addition of microbubbles to either
solution did not significantly increase the effect of these
agents on aortic systolic pressure . No significant changes
were noted in refs aerial or left ventricular end-diastolic
pressure or heart rate during any of the injections. Placement
of a critical stenosis in six dogs did not change the effects of
albumin solutions on left ventricular and systemic hemody-
numics significantly (Table I) .
Echocardiographic data. All three Rehografin solutions
caused a decrease in regional left ventricular systolic thick-
ening at 5 s, with subsequent return toward normal by 20 s
(Fig . 2D) . Left ventricular systolic thickening decreased by a
maximum of 15.0'_ 17
.0% with nonsonicated Renografin-76
.
The addition of microbubbles caused a decrease in wall
thickening of 30.0 ± 15 .0% for sonicated Rehografin-76
(p = 0.02) and of 26 ± 21% for hand-agitated Renografin-76
(p = 0
.02) . In comparison, albumin solutions did not
significantly alter regional left ventricular systolic thickening
(Fig . 2D) . The maximal decrease in thickening caused by
albumin solutions was 3 .0 ± 8 .2% for the 5 .8 µm albumin
microbubbles whereas the nonsonicated albumin and 2 .8 gem
albumin microbubbles decreased thickening by 0 .8 ± 10%
and 0
.6 ± 8
.6%, respectively . The addition of a c ;ties]
Stenosis in six dogs exaggerated the adverse effects of
hand-agitated Renografin-76 on regional systolic thickening
in the perfusion bed supplied by the stenosed vessel . How-
ever, this effect did not achieve statistical significance (Table
1)
. Such an effect was not seen with any of the albumin
solutions (Table I).
Videodensitownetric data are shown in Figure 3 . Hand-
agitated Renogrfin-76 produced the most contrast enhance-
ment (58 ± 28 gray levels) whereas 2
.9 gum albumin
microbubbles produced the least (20 ± 21 gray levels)
;
the levels of contrast enhancement produced by sonicated
Renogrfin-76 and 5 .9 µm albumin microbubbles were inter-
mediate and approximately the same (37 ± 22 and 43 ± 29
gray levels, respectively)
. Nonsonicated albumin and Reno-
gratin produced small, insignificant increases in video
intensity .
Pathologic Data
Table 2 depicts the pathologic changes noted in the heart,
brain and kidneys of the four sets of rabbits injected with
nonsonicated and sonicated albumin .
Effects on the heart . Normal saline solution, nonsoni-
cated albumin and 10 ml of sonicated albumin produced
JACC Vol
. 12, No . 4
0crohnr 1988:1039-47
Table 1
. Effects of Critical Coronary Stenosis on Left Ventricular
and Systemic Hemodynamics and Regional Left Ventricular
Systolic Thickening in Six Dogs
p=042.
similar effects on the heart . However, there was a higher
incidence of microinfarcts (80%) in rabbits injected with 20
ml of sonicated albumin .
Effects on the kidneys. No microinfarcts, capillary block-
age or hemorrhage was noted in the kidneys in any of the
rabbits.
Effects on the brain. No microinfarcts or capillary block-
ages were noted in the brain of any of the animals. Two of
the six rabbits receiving 20 ml of sonicated albumin showed
small areas of
intracerebral hemorrhage. This finding was
not noted in any other group .
No Stenosis Stenosis
Left ventricular dP/dt (% change)
Nonsonicated albumin 0!00 -2.0±4 .4
2 .9 pat albumin -6.5 ! 6.0 -2.2'_ 4 .9
5 .8pmalbumin -2.0±4 .5 -4.4
,
6.1
Nonsonicated Renogrzfin
.76 -17,9 *_ 9
.6
-16.5 T 10
.6
Sonicaled Renogmfin-76 -13.9 x 9 .6 -24.0 ± 6.9
Hand.agitated Renografin-76 -14.9 ! 9 .1 -17.0 '_ 9.8
Left ventricular end-diasmltc
pressure (% change)
Nonsonicated albumin 3.5 ± 5 .4 0 .0 ± 7.0
2 .9 gun albanin 5.5±4 .9 2 .5±5.6
5 .8pmalbumin 5 .7±9 .6 10±22.0
Nononicated Renogmfin-06 5.91- 16,0 9 .6 *- 10.0
Sonicated Renogmfin-76 0 .6 ^- 11 .0 18 .5 s 18.5
Hand.agitated Renogmfin-76 16.8 ± 23 .0 26 .1 ± 35.0
Left ventricular systolic pres sure
(% change)
Nonsonicated albumin -0.4 ± 2.2 -0.6 t 1.4
2
.9 pat albumin -1 .1 t 2.1 -0.1 t 3 .4
5 .8 µm albumin -0 .4x2.5 -1 .1 ±2 .1
Nonsonicated Renografin-76 -6 .2--4.2 -5.6 ± 3
.1
Sonicaled Renografin-76 -6.0 ± 6.3 -6.8 ± 3 .5
Hand-agitated Renogmfin-76 -8.8 *- 5.7 -9.1 ± 6 .1
Mean sonic pressure (% change)
Nonsonicated albumin
-1
.1 ± 0
.4 -0
.4 ± 1 .0
2.90malbumin -0.6±4 .5 -0.1±2 .5
5.8 gm albumin 0±4.4 0±0
Nonsonicated Renogmfin-76 -7.7 ± 3.7 -5 .7 m 2 .9
Salivated Rerogmfn-76 -7.0 *- 7 .3 -4 .2 ± 5.7
Hand-agitated Renografin-76 -10.5 ± 5 .5 -8 .3 ± 3 .9
Systolic thickening (% change)
Nansmicated albumin -1
.7'- 8 .4 -2 .0 ,
6.2
2.9 pat albumin -3.2 ± 6 .5
-2
.6 ± 6.6
5 .9 pat albumin -1.5±8.8 -6.0±12.0
Nonsonicated Renogmfin-76 -16 .0 t 15 .0 -22.0 ± 11.0
Sonicaled Renografin-76 -26 .0 ± 12 .0
-22
.0 t 14.0
Hand-agitated Renografin-76 -17 .0 ± 26
.0 -29.0 *- 14.0
JACC Vol. 12 . No. 4
Ocrohcr INK : 1019-07
=0. .rcw
. ua,na
1007 ® xuo-~xrnm ,¢,~a.r,
.-,e
Figure 3 . Comparison of the maximal contrast effect of all six
solutions derived from videodensitometdc analysis in 15 dogs . The
dependent axis represents the change in video intensity from base .
line (in arbitrary units) . Nonsonicaled albumin and Renografin-76
did not produce significant contrast opacification . Of the micrebub-
ble solutions, hand-agitated Renografin-76 produced the most opaci-
fication whereas 2.9 pm albumin microbubbles produced the least .
The peak contrast effects produced by sonicated Renografin and 5.8
pm albumin microbubbles were equivalent .
Discussion
Advantages of sonicated albumin microbubbles for contrast
echocardiography. At present, there is no technique for
readily and reliably measuring myocardial perfusion in vivo .
Imaging techniques such as tine-computed tomography and
digital subtraction angiography require injection of radi-
opaque contrast agents for measuring coronary transit times .
Such agents have significant effects on coronary blood flow
and left ventricular and systemic hemodynamics when in-
jected directly into the coronary circulation (17-19)
. Myo-
cardial contrast echocardiography is an emerging technique
that permits definition of coronary perfusion beds (1-5) and
has been shown to have the potential of quantilating regional
myocardial blood flow (6-9) and coronary blood flow reserve
(10,11). An agent used to assess regional myocardial blood
flow should not induce changes in coronary blood flow, left
ventricular function and systemic hemodynamics . Our re-
sults indicate that sonicated albumin microbubbles fit these
criteria. These microhubbles produce minimal changes in
peak positive left ventricular dP/dt and no significant
changes in coronary blood flow, left atrial, left ventricular
end-diastolic and end-systolic and aortic pressures and re-
KELLER ET AL .
	
1045
MY(l'AROUL P0)Nl RAST ECHOCARDIOGRAPilY
Table 2. P:uhologic Effects of Contrast Agents in 24 Rvbhils
Grnnp
A
Grnnp a Group C Grnap D
In 6) In = 6) In = 6) In = 61
'p = 0,08 compared with Group A
: *p =
0.45 compared
wIth
Grow A .
Group
A = Imrnaonic injection of 10 ml of aonsoniwred line niolm :
Group a - inrraaonic fnjecrion of lord of nr nsonicned albumin ; Group C -
inueslonic Injegion of 10 ml of sonicated aIinno : Group D = inrmaonic
injealor of '-0 ml of sonicmed albumin
.
gional left ventricular systolic thickening . Even in the pres-
ence of a critical coronary stenosis, these microbubbles
produce no adverse effects
. The injection of 5.8 pm albumin
bubbles produces contrast enhancement equivalent to Chat of
sonicated Renografin-76 without producing the adverse he-
modynamic effects noted with the latter . Furthermore, in
clinically relevant amounts, these microbubbles do not pro-
duce pathologic changes in the myocardium, brain and
kidneys .
Effects of the size of the microbubbles in the contrast agent .
The magnitude of the deleterious hemodynamic perturba-
tions that echo contrast agents produce is determined in part
by the size of the microbubbles . Gillam et al. (14) examined
the effects of a hand-agitated mixture of Renografin-76 and
saline solution in dogs . This agent induced a significant
increase in left ventricular end-diastolic pressure and a
decrease in peak positive left ventricular dP/dt and systemic
pressures . It also induced transient regional wu3 motion
abnormalities . Similar results were reported by others
(15,16). Levine et al. (17) used fluosol (an oxygen-carrying
agent) and reported that the addition of large microbubbles
produced by hand agitation caused significant alteration in
regional myocardial function.
Many of these adverse effects of myocardial contrast
agents have been minimized by the use of smaller microbub-
bles produced by sonication . Lang et al . (15) compared
sonicated and hand-agitated Renografin-76 in an animal
model
. Whereas both solutions decreased left ventricular
function, the decrer.rent produced by the hand-agitated
solution was significantly greater . Furthermore, the effects
of sonicated Renograhn-76 were not significantly different
from those produced by nonsonicated Renograhn-76. The
Mieroinfaras n6
1116 116
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Cupi/lary hlnckage a16 IV6 146 016
Hcmorrhacc 016 116 211, 1,6
Kidneys
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results of our present study are in agreement with these
fiadirgs. We have also previously (12) compared the effects
oh intracoronary injections of sonicated Renografin-76 with
those of nonsonicated Renografin-76 in humans and found
myocardial contrast echocardiography to be as safe as
routine coronary angiography under these conditions
.
Whereas our data support earlier observations that soni-
cation of Renografin-76 in itself does not produce additional
effects on coronary blood flow or systemic hcmodynamics,
there are some important differences . First, the addition of
microbubbles (even small ones) to Renografin-76 causes a
further decrease in left ventricular systolic thickening . These
findings are somewhat in discordance with those of Lang et
al . (15), who reported no change in left ventricular systolic
function when microbubbles were added to Renografin-76 .
Second, the addition of microbubbles to the albumin solution
results in a small but definite effect on peak positive left
ventricular dP/dt without causing any other adverse effects .
Finally, the presence of a critical coronary stenoses exagger-
ates the adverse effects of hand-agitated Renografin-76 on
regional function; this effect is not noted for albumin solu-
tions . In this regard, our data are in agreement with those of
Christensen et al . (I8), who also showed that Renografin-76
and other agents with large microbubbles further decrease
regional left ventricular systolic function in the presence of
critical coronary stenoses .
Meets of the carrier solutions constituting the contrast
agent. The carrier solution used for myocardial contrast
echocardiography is also an important determinant of hemo-
dynamic effects. For example, Renografin-76, which is cur-
rently used most often in the clinical setting for this appli-
cation (10-12), has direct myocardial depressant effects
resulting from its hyperosmolality and calcium chelating
properties (17-19) . Human albumin does not have these
properties and is reported to be safe in humans (27) . We
found that this agent in itself produces no significant changes
in coronary blood flow and regional systolic left ventricular
function and has negligible effects on left ventricular and
systemic hemodynamics. The addition of microbubbles only
slightly changes its effect on peak positive left ventricular
dP/dt without causing any additional hemodynamic effects or
changes in coronary blood flow .
Optimal contrast enhancement. As the ultrasound energy
reflected from a microbubble is related to the sixth power of
its diameter
(28), the larger the bubbles, the greater the
myocardial contrast enhancement . It is, therefore, not sur-
prising that in our experiments large bubbles produced by
hand agitation produced the most contrast enhancement,
whereas the 2.9 um sonicated albumin microbubbles pro-
duced the least
. However, hand-agitated microbubbles pro-
duce capillary blockage (29) whereas small sonicated micro-
bubbles pass readily through the microcirculation at the
velocity of red blood cells (22,30) . Our data suggest that the
5 .8,um albumin microbubbles are of ideal size, small enough
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to readily pass through the microcirculation and large
enough to provide adequate contrast enhancement .
Pathologic effects of sonicated mlerobubbtes . Although
albumin microbubbles seem to be ideal for myocardial
contrast echocardiography, unlike microbubbles produced
in other solutions, they have a long in vitro half-life . Their
long half-life may be due to the formation of an albumin
"shell." This shell has been demonstrated in vivo using
fluorescent labeling techniques (22), and probably consists of
albumin that has beer. denatured by heat generated during
the sonication process (the mean temperature of albumin
immediately after sonication is 65'C) . Although the implica-
tions of high temperature injectates were not examined in
this study, temperature should not be an issue with albumin
microbubbles, as their half-life is sufficiently long that one
may allow them to cool to body temperature before injec-
tion. The microbubbles of sonicated Renografin-76, how-
ever, have a short half-life that necessitates prompt injection
of this solution. One may theorize that the adverse hemody-
namic effects of sonicated Renografin-76 may, in part, be due
to its elevated temperature .
We examined the heart, kidneys and brain of rabbits 48 h
after injecting saline solution and nonsonicated and soni-
cated albumin into their arterial circulation to evaluate any
potential effects of 10 ml of these agents. We found no
evidence of any significant pathologic changes in the myo-
cardium, brain and kidneys after injection of this amount . In
contrast, we noted significant changes, especially microin-
farcts within the myocardium, after injection of twice this
amount, The adverse effects noted using the large doses may
in part be related to the pressure of injection, replacement of
most of the intraaortic blood volume of the rabbit with
sonicated albumin and possible hypersensitivity reaction to
human albumin. However, none of these possible mecha-
nisms could be adequately documented .
The 10 ml injection of sonicated Renografin in a 4 kg
rabbit is equivalent to an injection of 175 ml in a 70 kg adult
human . Normally, 5% of any solution injected into the
systemic circulation should enter the coronary circulation on
its first pass
. Therefore, a 175 ml intraaortic injection of a
solution should result in 9 ml of the agent entering the
coronary circulation, assuming that adequate mixing occurs .
As only 2 to 3 ml of this agent is required to produce optimal
myocardial contrast opacification, it should be safe to per-
form three or four consecutive intracoronary injections in
humans
.
Conclusions. This work is the first study demonstrating
the efficacy and safety of sonicated albumin as an intracoro-
nary contrast agent for use in myocardial contrast echocar-
diography. Contrast agents used previously have adverse
effects on coronary blood flow, left ventricular function and
systemic hemodynamics precluding their use as optimal
agents for quantitating regional myocardial perfusion. Soni-
cated albumin possesses minimal toxic properties and, in
JACC Vol. 12 . No- d
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clinically applicable amounts, appears to have no pathologic
effects on the myocarojum . brain and kidneys of abbits .
Albumin tnierobubbles have been shown to behave similarly
to red blood cells in the microcirculatioa . fanning a basis for
their use as tracers of red blond cell flow during myocardial
contrast echocardiography 1221 Preliminary observations
also suggest that sunicated albumin is capable of transit
through the pulmonary circulation such that a peripheral
injection of this agent causes opacification
of the left ven-
tricular cavity in the dog
(23) . Both the lack of effects on
coronary blood flow and hemodynamics and the ease of
operating an echocardiographic imaging system are two
dlglinel advantages of using myocardial contrast echocar-
diography with sonicated albumin microbubblcs to measure
myocardial blood flow.
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